Baylot, V., Andrieu, C., Katsogiannou, M., Taieb, D., Garcia, S., Giusiano, S., . . . Rocchi, P. (2011). OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer. Nature Publishing Group.
استشهاد بنمط شيكاغوBaylot, V., et al. OGX-427 Inhibits Tumor Progression and Enhances Gemcitabine Chemotherapy in Pancreatic Cancer. Nature Publishing Group, 2011.
MLA استشهادBaylot, V., et al. OGX-427 Inhibits Tumor Progression and Enhances Gemcitabine Chemotherapy in Pancreatic Cancer. Nature Publishing Group, 2011.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.